Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
40
OVID Quote, Financials, Valuation and Earnings
Last price:
$1.79
Seasonality move
:
-12.18%
Day range:
$1.77 - $1.88
52-week range:
$0.24 - $2.01
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
19.14x
P/B ratio:
2.84x
Volume:
1.1M
Avg. volume:
1.8M
1-year change:
84.21%
Market cap:
$126.8M
Revenue:
$566K
EPS (TTM):
-$0.51
Earnings Data
Next earnings date for OVID
Mar 10
2026
Most recent earnings per share
-$0.17
Missed by $0.02
(Nov 12/2025)
Consensus Estimate
-$0.15
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
OVID Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/10/2026 | Q4 | $62.6K | -- | -- | -$0.10 | -- |
| 11/12/2025 | Q3 | $170.4K | $132K | -$0.17 | -$0.15 | -$0.02 |
| 08/13/2025 | Q2 | $93.2K | $6.3M | -$0.07 | -$0.15 | $0.08 |
| 05/15/2025 | Q1 | $25K | $130K | -$0.14 | -$0.13 | -$0.01 |
| 03/11/2025 | Q4 | $187.5K | $76K | -$0.13 | -$0.17 | $0.04 |
| 11/12/2024 | Q3 | $70K | $173K | -$0.20 | -$0.23 | $0.03 |
| 08/13/2024 | Q2 | $52.9K | $169K | $0.12 | -$0.24 | $0.36 |
| 05/14/2024 | Q1 | $52.1K | $148K | -$0.17 | -$0.23 | $0.06 |
| 03/08/2024 | Q4 | $10M | $141.7K | -$0.22 | $0.25 | -$0.47 |
| 11/03/2023 | Q3 | -- | -- | -$0.16 | -- | -- |
| 08/04/2023 | Q2 | -- | -- | -$0.18 | -- | -- |
| 05/05/2023 | Q1 | -- | -- | -$0.19 | -- | -- |
| 03/13/2023 | Q4 | -- | -- | -$0.16 | -- | -- |
| 11/08/2022 | Q3 | -- | -- | -$0.17 | -$0.21 | $0.04 |
| 08/09/2022 | Q2 | -- | -- | -$0.21 | -$0.19 | -$0.02 |
| 05/10/2022 | Q1 | -- | -- | -$0.23 | -$0.21 | -$0.02 |
| 03/15/2022 | Q4 | -- | -- | -$0.38 | -$0.16 | -$0.22 |
| 11/10/2021 | Q3 | -- | -- | -$0.17 | -$0.18 | $0.01 |
| 08/16/2021 | Q2 | -- | -- | -$0.23 | -$0.16 | -$0.07 |
| 05/13/2021 | Q1 | -- | -- | $2.53 | $1.13 | $1.40 |
| 03/15/2021 | Q4 | -- | -- | -$0.34 | -$0.30 | -$0.04 |
| 11/12/2020 | Q3 | -- | -- | -$0.28 | -$0.35 | $0.07 |
| 08/10/2020 | Q2 | -- | -- | -$0.41 | -$0.35 | -$0.06 |
| 05/07/2020 | Q1 | -- | -- | -$0.37 | -$0.32 | -$0.05 |
| 03/11/2020 | Q4 | -- | -- | -$0.35 | -$0.39 | $0.04 |
| 11/08/2019 | Q3 | -- | -- | -$0.43 | -$0.36 | -$0.07 |
| 08/07/2019 | Q2 | -- | -- | -$0.34 | -$0.40 | $0.06 |
| 05/07/2019 | Q1 | -- | -- | -$0.46 | -$0.41 | -$0.05 |
| 03/07/2019 | Q4 | -- | -- | -$0.52 | -$0.55 | $0.03 |
| 11/08/2018 | Q3 | -- | -- | -$0.53 | -- | -- |
| 08/09/2018 | Q2 | -- | -- | -$0.53 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | -$0.54 | -- | -- |
| 03/29/2018 | Q4 | -- | -- | -$0.45 | -- | -- |
| 11/09/2017 | Q3 | -- | -- | -$0.38 | -- | -- |
| 08/10/2017 | Q2 | -- | -- | -$0.57 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$1.39 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$0.39 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.30 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$0.27 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$0.19 | -- | -- |
Ovid Therapeutics, Inc. Earnings Questions
-
How Much did Ovid Therapeutics, Inc. Generate in Revenue Last Quarter?
Ovid Therapeutics, Inc. reported $132K worth of top line sales in its most recent quarter.
-
Did Ovid Therapeutics, Inc. Beat Earnings Last Quarter?
Ovid Therapeutics, Inc. announced earnings per share of -$0.17 which represents a miss of analyst forecast a -$0.15 per share.
-
Is Ovid Therapeutics, Inc. Profitable?
Ovid Therapeutics, Inc. reported $115K that represents $0.00 per share over the last quarter.
-
What is the Analyst Consensus for Ovid Therapeutics, Inc. EPS Next Year?
Ovid Therapeutics, Inc.'s earnings are forecast to decrease from -$0.37 per share to -$0.41 per share next year representing a decrease of -21.38%.
-
When is Ovid Therapeutics, Inc.'s Earnings Date?
Ovid Therapeutics, Inc.'s next earnings date is March 10, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
